GlassScriptPhysician profile
Pragnesh A Patel
NPI 1568529006
$13,920.93
in general payments reported to CMS, 2019-2025
43 companies · $727 in 2025
The $727 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,167 · 2020: $1,581 · 2021: $2,003 · 2022: $3,980 · 2023: $1,673 · 2024: $1,789 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,189.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,846.86 | 2022-2024 | Smart Coil, Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,733.54 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $1,618.98 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,220.22 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $1,009.72 | 2019-2025 | Farxiga, Wainua |
| Cardiovascular Systems INC. | $756.57 | 2019-2022 | |
| Amgen INC. | $666.94 | 2019-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $414.64 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $384.85 | 2019-2024 | |
| Boston Scientific Corporation | $379.18 | 2019-2025 | Bodyguardian |
| Angiodynamics, INC. | $368.95 | 2024 | Auryon Laser System 100-120 Vac |
| Shockwave Medical, INC | $319.48 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.64 | 2019-2024 | Jardiance |
| Abiomed | $274.36 | 2019 | |
| Abbott Laboratories | $201.43 | 2020-2024 | Diamondback Peripheral, Aveir |
Show all 41 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pragnesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.